Pathogenetic pathways and novel pharmacotherapeutic targets in idiopathic pulmonary fibrosis

Pulmonary Pharmacology & Therapeutics
K M AntoniouNikolaos M Siafakas

Abstract

Idiopathic pulmonary fibrosis (IPF) is a poorly understood disease that usually leads to death within 5 years of diagnosis. Despite our better understanding of IPF pathogenesis, the etiology and the precise cellular and molecular mechanisms involved are not well known. Current therapies are of unproven benefit. The aim of this review is to identify possible candidate pathways that might offer novel therapeutic targets changing the natural course of this disease. Current therapeutic approaches target at apoptosis, epithelial replacement, fibroblasts/myofibroblasts, procoagulant activity, growth factors production, angiogenesis, Th1 and Th2 cytokines and oxidative stress. Increased epithelial cells apoptosis can contribute to fibrosis, while on the other hand, decreased fibroblast or myofibroblast apoptosis promotes fibrosis. Recent findings support the notion that therapy directed at either inhibition of angiogenic or augmentation of angiostatic CXC chemokines may be a novel approach in the treatment of IPF. Additionally, there is little doubt that the development of novel therapeutic strategies for pulmonary fibrosis should target some profibrotic growth factors and key type II cytokines, such as inteleukin-13. Importantly, per...Continue Reading

References

Dec 1, 1989·The American Review of Respiratory Disease·C KuhnJ A McDonald
Feb 1, 1989·The American Review of Respiratory Disease·A M CantinR G Crystal
Mar 1, 1994·The Journal of Clinical Investigation·T R UlichG F Pierce
Jan 7, 1998·Biochemical Pharmacology·S N GiriM D Pierschbacher
Dec 31, 1998·American Journal of Respiratory Cell and Molecular Biology·K KuwanoN Hara
Jul 7, 1999·The Journal of Clinical Investigation·A NakaoI Iwamoto
Mar 25, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S GodichaudJ Rosenbaum
Aug 17, 2000·Nitric Oxide : Biology and Chemistry·G GurujeyalakshmiS N Giri
Oct 13, 2000·American Journal of Respiratory and Critical Care Medicine·X Y ZhangK Shirato
Feb 15, 2001·Annals of Internal Medicine·M SelmanUNKNOWN American College of Chest Physicians
May 15, 2001·American Journal of Physiology. Lung Cellular and Molecular Physiology·M KolbJ Gauldie
Aug 25, 2001·The New England Journal of Medicine·T J Gross, G W Hunninghake
Dec 26, 2001·American Journal of Respiratory and Critical Care Medicine·M P KeaneR M Strieter
Jan 25, 2002·Respiratory Research·Moisés Selman, Annie Pardo
Jun 13, 2002·American Journal of Physiology. Lung Cellular and Molecular Physiology·Kamran AtabaiLorraine B Ware
Oct 2, 2002·Lancet·Hossein Ardeschir GhofraniFriedrich Grimminger
Oct 31, 2002·American Journal of Respiratory and Critical Care Medicine·Elisabetta A RenzoniRoland M Du Bois
Jan 24, 2003·Annual Review of Pharmacology and Toxicology·Shri N Giri
Sep 1, 1963·Thorax·M TURNER-WARWICK
Jan 9, 2004·The New England Journal of Medicine·Ganesh RaghuUNKNOWN Idiopathic Pulmonary Fibrosis Study Group
Feb 19, 2004·Drugs·Moisés SelmanJoseph P Lynch
Mar 27, 2004·American Journal of Respiratory and Critical Care Medicine·Robert M StrieterUNKNOWN Idiopathic Pulmonary Fibrosis Biomarkers Study Group
May 1, 2004·American Journal of Respiratory and Critical Care Medicine·Gregory P CosgroveG Scott Worthen
May 27, 2004·American Journal of Respiratory and Critical Care Medicine·Elisabetta A Renzoni
Jul 29, 2004·American Journal of Respiratory and Critical Care Medicine·Michael P Keane
Nov 26, 2004·American Journal of Respiratory and Critical Care Medicine·Philippe BonniaudJack Gauldie
Dec 9, 2004·Respiratory Research·Argyris TzouvelekisDemosthenes Bouros

❮ Previous
Next ❯

Citations

Jul 18, 2012·Proceedings of the American Thoracic Society·Barry S Shea, Andrew M Tager
Sep 3, 2011·Lung India : Official Organ of Indian Chest Society·Amartya MishraSnehasikta Swarnakar
Sep 29, 2011·Respiratory Research·Przemyslaw BlyszczukGabriela Kania
Dec 30, 2011·PloS One·Ismini LasithiotakiGeorge Sourvinos
Nov 6, 2007·Expert Opinion on Emerging Drugs·Mehrnaz Gharaee-KermaniMargaret R Gyetko
Mar 15, 2013·Expert Opinion on Investigational Drugs·Sushmita ChakrabortyAbhijit Ray
Jan 14, 2010·Connective Tissue Research·Katerina M AntoniouNikolaos M Siafakas
Oct 25, 2011·Paediatric Respiratory Reviews·Nadia NathanAnnick Clement
May 13, 2009·The International Journal of Biochemistry & Cell Biology·Harriet CorvolLoic Guillot
Jan 27, 2009·The Mount Sinai Journal of Medicine, New York·Adam S Morgenthau, Maria L Padilla
Jul 4, 2013·Respirology : Official Journal of the Asian Pacific Society of Respirology·Katerina M AntoniouAthol U Wells
Sep 18, 2015·American Journal of Respiratory Cell and Molecular Biology·Shanna L AshleyJeffrey C Horowitz
Jan 16, 2013·Journal of Ethnopharmacology·Xian-Mei ZhouJian-Xin Li
Jul 17, 2012·Journal of Ethnopharmacology·Mengli ChenWing Keung Liu
Jun 15, 2010·Respiratory Medicine·Wou Young ChungKwang Joo Park
Jul 25, 2014·European Journal of Pharmacology·Leila SafaeianGolnaz Vaseghi
Jul 27, 2010·Biochemical and Biophysical Research Communications·Sarah ParkJie-Young Song
Oct 1, 2016·European Journal of Pharmacology·George A MargaritopoulosKaterina M Antoniou
Oct 1, 2016·Pathophysiology : the Official Journal of the International Society for Pathophysiology·Enas A HamedDina Sabry
Dec 29, 2007·American Journal of Physiology. Lung Cellular and Molecular Physiology·Jami E MilamRaju C Reddy
Dec 30, 2008·American Journal of Physiology. Lung Cellular and Molecular Physiology·Nagina ParmarAnthony K C Chan
Jun 18, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Syed Amir AshrafSibte Hadi
Aug 1, 2019·Experimental and Therapeutic Medicine·Congying ZhaiYan Qu
Dec 22, 2010·European Journal of Medical Research·Tadeusz M ZielonkaE Skopinska-Rozewska
Oct 27, 2007·American Journal of Respiratory and Critical Care Medicine·Katerina M AntoniouAthol U Wells

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Basement Membranes

Basement membranes are thin, specialized extracellular matrices surrounding most tissues in all metazoans. Here is the latest research on basement membranes.